This retrospective, descriptive, and analytical study was conducted over a six-month period (January to June 2025) at the Cuomo Cardiac Center in Dakar, involving 39 consecutive adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Perioperative data were extracted from medical records, supplemented by systematic arterial blood gas analysis within the first six postoperative hours. Statistical analysis was performed using Sphinx Plus software. Results revealed a high prevalence of acid-base disorders (ABD) at 64.1% (25 patients). Acidosis was largely predominant (56.4%), categorized as respiratory (33.3%), metabolic (15.4%), and mixed (7.7%), while alkalosis remained marginal (7.7%). The study identified the intraoperative use of two or more sympathomimetic agents as a major risk factor, strongly correlated with the occurrence of an ABD (p = 0.005). Regarding prognosis, patients with an ABD had a significantly longer mean length of stay in the intensive care unit (4.76 days vs. 3.43 days). Finally, although the sample size limited statistical significance for certain variables, the impact on mortality was notable: all four recorded deaths (10.3%) occurred exclusively in acidotic patients. These findings underscore the imperative for increased monitoring and early correction of imbalances, particularly in patients requiring heavy hemodynamic support.
| Published in | International Journal of Cardiovascular and Thoracic Surgery (Volume 12, Issue 2) |
| DOI | 10.11648/j.ijcts.20261202.11 |
| Page(s) | 22-27 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2026. Published by Science Publishing Group |
Cardiac Surgery, Acid-base Disorders, Acidosis, Prognosis
Ground | Effective | Percentage (%) |
|---|---|---|
HTA | 7 | 17.95 |
Diabetes | 4 | 10.25 |
Vascular disease | 3 | 7.69 |
Obesity | 2 | 5.13 |
Smoking | 2 | 5.13 |
Sickle cell disease | 2 | 5.13 |
Asthma | 1 | 2.56 |
Chronic kidney failure | 1 | 2.56 |
Dyslipidemia | 1 | 2.56 |
Treatment | Effective | Percentage (%) |
|---|---|---|
Loop diuretic | 25 | 64.1 |
Anti-aldosterone | 25 | 64.1 |
ACE inhibitor | 13 | 33.3 |
Betablockers | 11 | 28.2 |
Antiarrhythmics | 4 | 10.3 |
Statins | 3 | 7.7 |
Calcium channel blockers | 2 | 5.1 |
Sympathomimetic Association | Effective | Percentage (%) |
|---|---|---|
NAD alone | 20 | 51.3 |
Milrinone alone | 1 | 2.6 |
NAD+Milrinone | 5 | 12.8 |
NAD+Dobutamine | 7 | 28.2 |
NAD+Dobutamine+Milrinone | 1 | 2.6 |
NAD+Adrenaline+Milrinone | 3 | 7.7 |
No sympathomimetics | 4 | 10.3 |
Total | 39 | 100% |
Data | Acid-base disorders: No | Acid-base disturbances: Yes | P-value (p) |
|---|---|---|---|
Age (average in years) | 39.21 | 41.96 | 0.638 |
Sex | M(4/14), F(10/25) | M(10/14), F(15/25) | 0.475 |
Type of surgery | Valvular (12/30), Bypass (0/4), Ascending aorta (2/4), Congenital (0/1) | Valvular (18/30), Bypass (4/4), Ascending aorta (2/4), Congenital (1/1) | 0.338 |
Diuretic treatment | No (5/14), Yes (9/25) | No (9/14), Yes (16/25) | 0.451 |
FEVG (average in%) | 63.43 | 61.92 | 0.572 |
Hb (average in g/dl) | 12.56 | 12.10 | 0.346 |
Kidney damage (GFR) | No (10/21), Yes (4/18) | No (11/21), Yes (14/18) | 0.099 |
Intraoperative sympathomimetics | No (3/4) Yes (11/35) | No (1/4) Yes (24/35) | 0.085 |
Number ≥ 2 sympathomimetics | No (13/25), Yes (1/14) | No (12/25), Yes (13/14) | 0.005 |
CEC duration (average in min) | 104.00 | 133.64 | 0.098 |
Clamping time (average in minutes) | 79.93 | 100.48 | 0.103 |
Temperature during CEC | Normothermia (5/19), Hypothermia (9/20) | Normothermia (14/19), Hypothermia (11/20) | 0.224 |
Tabletop extubation | No (10/29), Yes (4/10) | No (19/29), Yes (6/10) | 0.753 |
CEC | Extracorporeal Circulation |
ABD | Acid-Base Disorders |
BE | Base Excess |
PaCO₂ | Arterial Carbon Dioxide Pressure |
IAP | Invasive Arterial Pressure |
CVP | Central Venous Pressure |
TEE | Transesophageal Echocardiography |
LVEF | Left Ventricular Ejection Fraction |
NAD | Norepinephrine |
Hb | Hemoglobin |
GFR | Glomerular Filtration Rate |
HR | Hazard Ratio (Instantaneous Relative Risk) |
| [1] | Zante B, Reichenspurner H, Kubik M, Kluge S, Schefold JC, Pfortmueller CA. Base excess is superior to lactate-levels in prediction of ICU mortality after cardiac surgery. PLoS ONE. 2018; 13(10): e0205309. |
| [2] | Jakob SM, Stanga Z. Perioperative metabolic changes in patients undergoing cardiac surgery. Nutrition. 2010; 26(4): 349-353. |
| [3] | Maillet JM, Le Besnerais P, Cantoni M, Natal P, Ruffenach A, Lessana A. Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest. 2003; 123(5): 1361-1366. |
| [4] | Ranucci M, De Toffol B, Isgro G, Vicentini M, Conti D, Romitti F. Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care. 2006; 10(6): R187. |
| [5] | Van Thiel RJ, Koopman SR, Takkenberg JJM, ten Harkel ADJ, Bogers AJJC. Metabolic alkalosis after pediatric cardiac surgery. Eur J Cardiothorac Surg. 2005; 28(2): 229-233. |
| [6] | Cohn LH, ed. Cardiac Surgery in the Adult. 5th ed. New York, NY: McGraw-Hill Education; 2017. |
| [7] | Hernandez AF, Newby LK, O'Connor CM. Preoperative evaluation for major noncardiac surgery: focusing on heart failure. Arch Intern Med. 2004 Sep 13; 164(16): 1729-36. |
| [8] | Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012; 379(9819): 953-964. |
| [9] | Khanna U, Kurtzman NA. Metabolic alkalosis. Respir Care. 2001 Apr; 46(4): 354-65. |
| [10] | Laudignon N, Ciampi A, Coupal L, Chemtob S, Aranda JV. Furosemide and ethacrynic acid: risk factors for the occurrence of serum electrolyte abnormalities and metabolic alkalosis in newborns and infants. Acta Paediatr Scand. 1989; 78(1): 133-135. |
| [11] | Algarni KD, Maganti M, Yau TM. Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20 years. Ann Thorac Surg. 2011; 92(5): 1678-1684. |
| [12] | Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon J et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation (Traffic erratum). 2009; 119(18): 2444-2453. |
| [13] | Lassnigg A, Schmidlin D, Mouhieddine M, Backmaan LM, Druml W, Bauer P et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004; 15(6): 1597-1605. |
| [14] | Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009; 23(2): 223-231. |
| [15] | Levine WC, Mehta V, Landesberg G. Anesthesia for cardiac surgery. In: Miller's Anesthesia. 8th ed. Philadelphia: Elsevier Saunders; 2015: 1992-2048. |
| [16] | Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006; 12(4): 315-321. |
| [17] | Hajjar LA, Almeida JP, Fukushima JT, et al. High lactate levels are predictors of major complications after cardiac surgery. J Thorac Cardiovasc Surg. 2013; 146(2): 455-460. |
| [18] | Canet J, Gallart L, Gomar C, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010; 113(6): 1338-1350. |
| [19] | Orchard CH, Kentish JC. Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol. 1990; 258(6 Pt 1): C967-C981. |
| [20] | Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. Ann Intern Med. 1990; 112(7): 492-498. |
APA Style
Ba, E. B., Toure, M., Ndiaye, P. I., Diop, G., Sene, E. B., et al. (2026). Exploration of Acid-base Disorders in the Post-operative Post-cardiac Surgery Period. International Journal of Cardiovascular and Thoracic Surgery, 12(2), 22-27. https://doi.org/10.11648/j.ijcts.20261202.11
ACS Style
Ba, E. B.; Toure, M.; Ndiaye, P. I.; Diop, G.; Sene, E. B., et al. Exploration of Acid-base Disorders in the Post-operative Post-cardiac Surgery Period. Int. J. Cardiovasc. Thorac. Surg. 2026, 12(2), 22-27. doi: 10.11648/j.ijcts.20261202.11
AMA Style
Ba EB, Toure M, Ndiaye PI, Diop G, Sene EB, et al. Exploration of Acid-base Disorders in the Post-operative Post-cardiac Surgery Period. Int J Cardiovasc Thorac Surg. 2026;12(2):22-27. doi: 10.11648/j.ijcts.20261202.11
@article{10.11648/j.ijcts.20261202.11,
author = {Elhadji Boubacar Ba and Maïmouna Toure and Papa Ibrahima Ndiaye and Goumbo Diop and Etienne Birame Sene and Abdoulaye Gueye and Elhadji Malick Diao and Marie Victoire Sene and Ulimata Diop and Oumar Kane and Elisabeth Diouf},
title = {Exploration of Acid-base Disorders in the Post-operative Post-cardiac Surgery Period},
journal = {International Journal of Cardiovascular and Thoracic Surgery},
volume = {12},
number = {2},
pages = {22-27},
doi = {10.11648/j.ijcts.20261202.11},
url = {https://doi.org/10.11648/j.ijcts.20261202.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcts.20261202.11},
abstract = {This retrospective, descriptive, and analytical study was conducted over a six-month period (January to June 2025) at the Cuomo Cardiac Center in Dakar, involving 39 consecutive adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Perioperative data were extracted from medical records, supplemented by systematic arterial blood gas analysis within the first six postoperative hours. Statistical analysis was performed using Sphinx Plus software. Results revealed a high prevalence of acid-base disorders (ABD) at 64.1% (25 patients). Acidosis was largely predominant (56.4%), categorized as respiratory (33.3%), metabolic (15.4%), and mixed (7.7%), while alkalosis remained marginal (7.7%). The study identified the intraoperative use of two or more sympathomimetic agents as a major risk factor, strongly correlated with the occurrence of an ABD (p = 0.005). Regarding prognosis, patients with an ABD had a significantly longer mean length of stay in the intensive care unit (4.76 days vs. 3.43 days). Finally, although the sample size limited statistical significance for certain variables, the impact on mortality was notable: all four recorded deaths (10.3%) occurred exclusively in acidotic patients. These findings underscore the imperative for increased monitoring and early correction of imbalances, particularly in patients requiring heavy hemodynamic support.},
year = {2026}
}
TY - JOUR T1 - Exploration of Acid-base Disorders in the Post-operative Post-cardiac Surgery Period AU - Elhadji Boubacar Ba AU - Maïmouna Toure AU - Papa Ibrahima Ndiaye AU - Goumbo Diop AU - Etienne Birame Sene AU - Abdoulaye Gueye AU - Elhadji Malick Diao AU - Marie Victoire Sene AU - Ulimata Diop AU - Oumar Kane AU - Elisabeth Diouf Y1 - 2026/02/27 PY - 2026 N1 - https://doi.org/10.11648/j.ijcts.20261202.11 DO - 10.11648/j.ijcts.20261202.11 T2 - International Journal of Cardiovascular and Thoracic Surgery JF - International Journal of Cardiovascular and Thoracic Surgery JO - International Journal of Cardiovascular and Thoracic Surgery SP - 22 EP - 27 PB - Science Publishing Group SN - 2575-4882 UR - https://doi.org/10.11648/j.ijcts.20261202.11 AB - This retrospective, descriptive, and analytical study was conducted over a six-month period (January to June 2025) at the Cuomo Cardiac Center in Dakar, involving 39 consecutive adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Perioperative data were extracted from medical records, supplemented by systematic arterial blood gas analysis within the first six postoperative hours. Statistical analysis was performed using Sphinx Plus software. Results revealed a high prevalence of acid-base disorders (ABD) at 64.1% (25 patients). Acidosis was largely predominant (56.4%), categorized as respiratory (33.3%), metabolic (15.4%), and mixed (7.7%), while alkalosis remained marginal (7.7%). The study identified the intraoperative use of two or more sympathomimetic agents as a major risk factor, strongly correlated with the occurrence of an ABD (p = 0.005). Regarding prognosis, patients with an ABD had a significantly longer mean length of stay in the intensive care unit (4.76 days vs. 3.43 days). Finally, although the sample size limited statistical significance for certain variables, the impact on mortality was notable: all four recorded deaths (10.3%) occurred exclusively in acidotic patients. These findings underscore the imperative for increased monitoring and early correction of imbalances, particularly in patients requiring heavy hemodynamic support. VL - 12 IS - 2 ER -